The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Influx of Extended-Spectrum -Lactamase--Producing Enterobacteriaceae into the Hospital
Abstract
BACKGROUND: The prevalence of infections caused by extended-spectrum beta -lactamase (ESBL)-producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies. METHODS: Isolates from 2 patient cohorts--patients with gram-negative bacteremia within 2 days after admission and patients screened for fecal colonization at admission--were assessed for ESBL production. ESBL phenotype was confirmed according to Clinical and Laboratory Standards Institute guidelines. Predictors of ESBL phenotype were examined by univariate and multivariate analyses. RESULTS: Of 80 Enterobacteriaceae isolates from blood samples obtained at admission to the hospital, 13.7% produced ESBL. Thirty-eight patients with ESBL-positive isolates and 72 with ESBL-negative isolates were included in a case-control study. Predictors of ESBL production were male sex and nursing home residence (area under receiver operator characteristic curve, 0.7). Of 241 persons screened at admission, 26 (10.8%) had fecal carriage of ESBL-producing Enterobacteriaceae. Predictors of fecal carriage were poor functional status, antibiotic use, chronic renal insufficiency, liver disease, and use of histamine2 blockers (area under receiver operator characteristic curve, 0.8). Four (15.4%) of the 26 individuals with fecal carriage had subsequent bacteremia with ceftazidime-resistant Enterobacteriaceae, compared with 1 (0.5%) noncarrier (odds ratio, 38.9; P<.001). Of 80 ESBL-producing Enterobacteriaceae isolates obtained at admission, 65 were health care associated, and 15 were community acquired. The 15 community-acquired ESBL-producing Enterobacteriaceae belonged to diverse clones. The most prevalent ESBL gene among these isolates was CTX-M-2 (found in 53.3% of the isolates). CONCLUSIONS: We report high rates of bacteremia and colonization with ESBL-producing Enterobacteriaceae at admission to our institution, which may undermine infection-control measures and complicate the selection of empirical treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2233-2239.1995 · Cited by 8,204
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Friedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Gram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
The Use of Analytical Isoelectric Focusing for Detection and Identification of -Lactamases
MATTHEW, M., HARRIS, A. M., MARSHALL, M. J., & ROSS, G. W. (1975) · Journal of General Microbiology · doi:10.1099/00221287-88-1-169 · Cited by 688
Paterson, D. L., Ko, W.-C., Gottberg, A. V., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00008 · Cited by 631
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Wiener, J. (1999) · JAMA · doi:10.1001/jama.281.6.517 · Cited by 485
Rodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Colodner, R., Rock, W., Chazan, B., Keller, N., Guy, N., Sakran, W., & Raz, R. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1084-2 · Cited by 364
Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., & Kim, E.-C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1481-1491.2002 · Cited by 357
Valverde, A., Coque, T. M., Sánchez-Moreno, M. P., Rollán, A., Baquero, F., & Cantón, R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4769-4775.2004 · Cited by 333
Peña, C., Pujol, M., Ardanuy, C., Ricart, A., Pallares, R., Liñares, J., Ariza, J., & Gudiol, F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.53 · Cited by 311
Schiappa, D. A., Hayden, M. K., Matushek, M. G., Hashemi, F. N., Sullivan, J., Smith, K. Y., Miyashiro, D., Quinn, J. P., Weinstein, R. A., & Trenholme, G. M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.529 · Cited by 248
Ouellette, M., Bissonnette, L., & Roy, P. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7378 · Cited by 238
Du, B., Long, Y., Liu, H., Chen, D., Liu, D., Xu, Y., & Xie, X. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1521-1 · Cited by 207
Coque, T. M., Oliver, A., Pérez-Díaz, J. C., Baquero, F., & Cantón, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.500-510.2002 · Cited by 197
Pitout, J. D. D., Hanson, N. D., Church, D. L., & Laupland, K. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421094 · Cited by 192
Schwaber, M. J., Navon-Venezia, S., Schwartz, D., & Carmeli, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2137-2139.2005 · Cited by 160
Self-citationNoller, A. C., McEllistrem, M. C., Stine, O. C., Morris, J. G., Boxrud, D. J., Dixon, B. W., & Harrison, L. H. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.2.675-679.2003 · Cited by 158
Arpin, C., Dubois, V., Coulange, L., André, C., Fischer, I., Noury, P., Grobost, F., Brochet, J.-P., Jullin, J., Dutilh, B., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3506-3514.2003 · Cited by 157
Sequence of PSE-2 beta-lactamase
Huovinen, P., Huovinen, S., & Jacoby, G. A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.134 · Cited by 150
Oliver, A., Pérez-Díaz, J. C., Coque, T. M., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.616-620.2001 · Cited by 107
High, K. P., Bradley, S., Loeb, M. B., Palmer, R. M., Quagliarello, V., & Yoshikawa, T. T. (2004) · Clinical Infectious Diseases · doi:10.1086/426082 · Cited by 106
Extended-Spectrum Beta-Lactamases among Enterobacter Isolates Obtained in Tel Aviv, Israel
Schlesinger, J., Navon‐Venezia, S., Chmelnitsky, I., Hammer-Muntz, O., Leavitt, A., Gold, H. S., Schwaber, M. J., & Carmeli, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1150-1156.2005 · Cited by 82
Self-citationBorer, A., Moran‐Gilad, J., Menashe, G., Peled, N., Riesenberg, K., & Schlaeffer, F. (2002) · PubMed · Cited by 52
Schwaber, M. J., Raney, P. M., Rasheed, J. K., Biddle, J. W., Williams, P., McGowan, J. E., & Tenover, F. C. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.294-298.2004 · Cited by 52
Self-citationCTX-M extended-spectrum beta-lactamase arrives in the UK
Alobwede, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg096 · Cited by 49
Observations of nurses' treatment of leg and foot ulcers in community health care
Ribu, E. (2003) · Journal of Wound Ostomy and Continence Nursing · doi:10.1016/s1071-5754(03)00435-2 · Cited by 31
Salt-wasting bronchorrhea and its mechanisms
Jh, D. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.137.6.791 · Cited by 25
CTX-M–Type β-Lactamases Affect CommunityEscherichia coliTreatment, Greece
Pournaras, S., Ikonomidis, A., Sofianou, D., Tsakris, A., & Maniatis, A. N. (2004) · Emerging infectious diseases · doi:10.3201/eid1006.031031 · Cited by 18
Cited by
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Tacconelli, E., Cataldo, M. A., Dancer, S. J., De Angelis, G., Falcone, M., Frank, U., Kahlmeter, G., Pan, A., Petrosillo, N., Rodríguez-Baño, J., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12427 · Cited by 864
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
Metadata
- Authors
- Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., & Carmeli, Y.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-01
- Volume
- 42
- Issue
- 7
- Pages
- 925-934
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2132314433
- Cited by
- 317
- References
- 34
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.